Moore Capital Management, LP Horizon Therapeutics Public LTD CO Transaction History

Moore Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $2.89 Million - $3.37 Million	-30,000 Reduced 30.0%	70,000 $7.2 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $4.08 Million - $4.31 Million	38,000 Added 61.29%	100,000 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.87 Million - $7.06 Million	62,000 New	62,000 $7.06 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $1.8 Million - $2.39 Million	-25,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $1.38 Million - $2 Million	25,000 New	25,000 $1.94 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.